TFPI

tissue factor pathway inhibitor

Basic information

Region (hg38): 2:187464230-187565760

Previous symbols: [ "LACI" ]

Links

ENSG00000003436 ∙ NCBI:7035 ∙ OMIM:152310 ∙ HGNC:11760 ∙ Uniprot:P10646 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Transcripts

Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 61.

Transcript ID	Protein ID	Coding exons	MANE Select	MANE Plus Clinical
NM_006287.6	NP_006278.1	7	yes	-
ENST00000233156.9	ENSP00000233156.3	7	yes	-
NM_001032281.4	NP_001027452.1	6	-	-
NM_001318941.3	NP_001305870.1	6	-	-

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TFPI gene.

• not_specified (15 variants)
• not_provided (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFPI gene is commonly pathogenic or not. These statistics are base on transcript: NM_006287.6. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Effect	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous			1			1
missense			17		1	18
nonsense						0
start loss						0
frameshift						0
splice donor/acceptor (+/-2bp)			3			3
Total	0	0	21	0	1

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
TFPI	protein_coding	protein_coding	ENST00000233156	7	101531

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
		125502	0	7	125509	0.0000279

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	1.31	113	159	0.709	0.00000798	2021
Missense in Polyphen		27	56.2	0.48043		741
Synonymous	0.593	48	53.5	0.897	0.00000265	523
Loss of Function	2.81	4	16.2	0.247	9.92e-7	187

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.00	0.00
Ashkenazi Jewish	0.00	0.00
East Asian	0.00	0.00
Finnish	0.0000463	0.0000462
European (Non-Finnish)	0.0000484	0.0000440
Middle Eastern	0.00	0.00
South Asian	0.0000435	0.0000327
Other	0.00	0.00

dbNSFP

Source: dbNSFP

• Function: FUNCTION: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.
• Pathway: Complement and coagulation cascades - Homo sapiens (human);Integrated Breast Cancer Pathway;Dengue-2 Interactions with Complement and Coagulation Cascades;Complement and Coagulation Cascades;Extrinsic Pathway of Fibrin Clot Formation;Hemostasis;Formation of Fibrin Clot (Clotting Cascade);Syndecan-4-mediated signaling events;extrinsic prothrombin activation pathway (Consensus)

Recessive Scores

• pRec: 0.321

Intolerance Scores

• loftool: 0.754
• rvis_EVS: 0.33
• rvis_percentile_EVS: 73.27

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: E
• gene_indispensability_score: 0.930

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Gene ontology

• Biological process: blood coagulation;blood coagulation, extrinsic pathway;negative regulation of endopeptidase activity;negative regulation of blood coagulation;response to estradiol;cellular response to lipopolysaccharide;cellular response to interleukin-1;cellular response to steroid hormone stimulus
• Cellular component: extracellular region;extracellular space;endoplasmic reticulum;plasma membrane;caveola;cell surface;organelle membrane;anchored component of membrane
• Molecular function: endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity